Suppression of Melanoma-Associated Neoangiogenesis by Bevacizumab

Archives of Dermatology
doi 10.1001/archdermatol.2007.38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Bevacizumab Versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated With Branch Retinal Vein Occlusion

Korean journal of ophthalmology : KJO
Medicine
2018English

Suppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown System

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2018English

First Case of Melanoma-Associated Retinopathy With Conjunctival Melanoma

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

Correlated Suppression by 5-Bromodeoxyuridine of Tumorigenicity and Plasminogen Activator in Mouse Melanoma Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1975English

Anti–melanoma Differentiation–associated Gene 5 Dermatomyositis Complicated by Myopericarditis

JAAD Case Reports
Dermatology
2019English

Suppression of Growth and Hepatic Metastasis of Murine B16FO Melanoma Cells by a Novel Nutrient Mixture

Oncology Reports
MedicineCancer ResearchOncology
1994English

Memory T Cells Are Uniquely Resistant to Melanoma-Induced Suppression

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2012English

Vascular Endothelial Growth Factor and Hepatic Neoangiogenesis in Hepatitis C Associated Chronic Liver Disease

Sohag Medical Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy